MedTrace Logo

Epidural Nalbuphine for Postcesarean Epidural Morphine Induced Pruritus

NCT00707824 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 165

Last updated 2008-07-08

No results posted yet for this study

Summary

Can epidural nalbuphine reduce incidence or severity of epidural morphine induced pruritus in patient undergoing cesarean section?

Conditions

  • Cesarean Section

Interventions

DRUG

nalbuphine

nalbuphine 5 mg epidural

DRUG

nalbuphine

nalbuphine 10 mg epidural

OTHER

NSS

NSS

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Orawan Pongraweewan, MD · Mahidol University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
FACTORIAL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2000-06-30
Primary Completion
2005-12-31
Completion
2006-02-28

Countries

  • Thailand

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00707824 on ClinicalTrials.gov